People with a history of cognitively stimulating occupations during their 30s, 40s, 50s, and 60s had a lower risk of mild cognitive impairment and dementia after age 70.
Columbia neuroscientists have identified a genetic mutation that fends off Alzheimer's in people at high risk and could lead to a new way to protect people from the disease.
With funding from the Ultra-rare Gene-based Therapy Network, scientists at Columbia and the n-Lorem Foundation will create tailor-made gene-based therapies for people with rare forms of ALS.
Columbia neurologists and engineers are using a robotic device to investigate how Parkinson’s affects the ability to walk and respond to balance perturbations.
A new study suggests a smell test can identify people with mild cognitive impairment–often a precursor to Alzheimer’s–who may benefit from cholinesterase inhibitors.
New Zika research from Columbia University suggests that high rates of microcephaly in Brazil were not caused by new mutations in the virus, as previously believed.